{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:04:00Z","timestamp":1790129040696,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["2018-T1\/BMD-10731"],"award-info":[{"award-number":["2018-T1\/BMD-10731"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PID2023-1479-47OB-100"],"award-info":[{"award-number":["PID2023-1479-47OB-100"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurot.2026.e01062","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:12:43Z","timestamp":1788538363000},"page":"e01062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological modulation with the LXR agonist T0901317 attenuates motor pathology in the SOD1G93A mouse model of ALS"],"prefix":"10.1016","volume":"23","author":[{"given":"Luis C.","family":"Fern\u00e1ndez-Beltr\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Garc\u00eda-Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Javaloyes Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Jim\u00e9nez-Coca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Jim\u00e9nez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fern\u00e1ndez-Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Godoy-Corchuelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Portero-Ot\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Corrochano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e01062_bib1","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01062_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neurot.2026.e01062_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051105","article-title":"Lipid metabolic alterations in the ALS-FTD spectrum of disorders","volume":"10","author":"Godoy-Corchuelo","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurot.2026.e01062_bib4","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis symbol","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e01062_bib5","doi-asserted-by":"crossref","first-page":"E1835","DOI":"10.1212\/WNL.0000000000009322","article-title":"Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis","volume":"94","author":"Ingre","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e01062_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.838141","article-title":"Body complexion and circulating lipids in the risk of TDP-43 related disorders","volume":"14","author":"Esteban-Garc\u00eda","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neurot.2026.e01062_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.25431","article-title":"Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis","volume":"85","author":"Bandres-Ciga","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2026.e01062_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035333","article-title":"Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS","volume":"7","author":"Diekstra","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e01062_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj0264","article-title":"Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS","volume":"14","author":"Hop","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurot.2026.e01062_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1194\/jlr.P071639","article-title":"Defective cholesterol metabolism in amyotrophic lateral sclerosis","volume":"58","author":"Abdel-Khalik","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.neurot.2026.e01062_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab143","article-title":"Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression","volume":"3","author":"Sol","year":"2021","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurot.2026.e01062_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92112-3","article-title":"Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders","volume":"11","author":"Area-Gomez","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e01062_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/21678421.2020.1730904","article-title":"A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis","volume":"21","author":"Fern\u00c1ndez-Eulate","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurot.2026.e01062_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.10312","article-title":"Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress - induced death of motor neurons in amyotrophic lateral sclerosis","volume":"52","author":"Cutler","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2026.e01062_bib15","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1523\/JNEUROSCI.1388-20.2020","article-title":"Neutral lipid cacostasis contributes to disease pathogenesis in amyotrophic lateral sclerosis","volume":"40","author":"Dodge","year":"2020","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2026.e01062_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179553","article-title":"A transcriptomic meta-analysis shows lipid metabolism dysregulation as an early pathological mechanism in the spinal cord of sod1 mice","volume":"22","author":"Fern\u00e1ndez-Beltr\u00e1n","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2026.e01062_bib17","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurot.2026.e01062_bib18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-Genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neurot.2026.e01062_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurot.2026.e01062_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.neurot.2026.e01062_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","article-title":"TDP-43 loss and ALS-Risk SNPs drive mis-splicing and depletion of UNC13A","volume":"603","author":"Brown","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01062_bib22","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1038\/s41598-024-52439-z","article-title":"Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1G93A mice by reducing inflammatory pathways in the adipose tissue","volume":"14","author":"Fern\u00e1ndez-Beltr\u00e1n","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e01062_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bcp.2018.07.049","article-title":"Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis","volume":"157","author":"Rodr\u00edguez-Cueto","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neurot.2026.e01062_bib24","article-title":"In vivo electrophysiological measurement of compound muscle action potential from the forelimbs in mouse models of motor neuron degeneration","volume":"2018","author":"Pollari","year":"2018","journal-title":"JoVE J"},{"key":"10.1016\/j.neurot.2026.e01062_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/metabo5020389","article-title":"An efficient single phase method for the extraction of plasma lipids","volume":"5","author":"Alshehry","year":"2015","journal-title":"Metabolites"},{"key":"10.1016\/j.neurot.2026.e01062_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.chembiol.2018.10.008","article-title":"High-throughput plasma lipidomics: detailed mapping of the associations with cardiometabolic risk factors","volume":"26","author":"Huynh","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.neurot.2026.e01062_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106437","article-title":"TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43","volume":"193","author":"Godoy-Corchuelo","year":"2024","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurot.2026.e01062_bib28","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.neurobiolaging.2009.07.005","article-title":"Liver X receptor activation restores memory in aged AD mice without reducing amyloid","volume":"32","author":"Vanmierlo","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurot.2026.e01062_bib29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3233\/JAD-132789","article-title":"Improvement of memory deficits and A\u03b2 clearance in aged APP23 mice treated with a combination of anti-A\u03b2 antibody and LXR agonist HHS public access","volume":"41","author":"Fitz","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurot.2026.e01062_bib30","series-title":"Neurobiology of disease liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice","author":"Fitz","year":"2010"},{"key":"10.1016\/j.neurot.2026.e01062_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172161","article-title":"Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice","volume":"12","author":"Carter","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e01062_bib32","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/1873-3468.12702","article-title":"Liver X receptors link lipid metabolism and inflammation","volume":"591","author":"Schulman","year":"2017","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neurot.2026.e01062_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12974-024-03056-0","article-title":"LXR agonism for CNS diseases: promises and challenges","volume":"21","author":"Zhang","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2026.e01062_bib34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12035-013-8461-3","article-title":"LXR agonists: new potential therapeutic drug for neurodegenerative diseases","volume":"48","author":"Xu","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2026.e01062_bib35","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1073\/pnas.0500634102","article-title":"Inactivation of liver X receptor \u03b2 leads to adult-onset motor neuron degeneration in Male mice","volume":"102","author":"Andersson","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2026.e01062_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/21678421.2018.1433689","article-title":"Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects","volume":"19","author":"Xu","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurot.2026.e01062_bib37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s12035-017-0453-2","article-title":"Liver X receptor genes variants modulate ALS phenotype","volume":"55","author":"Mouzat","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2026.e01062_bib38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/21678421.2017.1407796","article-title":"Riluzole does not improve lifespan or motor function in three ALS mouse models","volume":"19","author":"Hogg","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurot.2026.e01062_bib39","article-title":"Electrophysiologic biomarkers for assessing disease progression and the effect of riluzole in SOD1 G93A ALS mice","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e01062_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","article-title":"Effects of gender in amyotrophic lateral sclerosis","volume":"7","author":"McCombe","year":"2010","journal-title":"Gend Med"},{"key":"10.1016\/j.neurot.2026.e01062_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2005.02.006","article-title":"Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS","volume":"236","author":"Heiman-Patterson","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurot.2026.e01062_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JND-140068","article-title":"Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: a meta-analysis","volume":"2","author":"Pfohl","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.neurot.2026.e01062_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2015.00103","article-title":"The sexual dimorphism of lipid kinetics in humans","volume":"6","author":"Santosa","year":"2015","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.neurot.2026.e01062_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00415-012-6665-5","article-title":"Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis","volume":"260","author":"De Jong","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.neurot.2026.e01062_bib46","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.celrep.2018.05.048","article-title":"Sex-specific features of microglia from adult mice","volume":"23","author":"Villa","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2026.e01062_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044998","article-title":"Myelin-derived lipids modulate macrophage activity by liver X receptor activation","volume":"7","author":"Bogie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e01062_bib48","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1073\/pnas.1424951112","article-title":"Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum","volume":"112","author":"Meffre","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2026.e01062_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.steroids.2015.02.003","article-title":"Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7\u03b2-hydroxycholesterol-, or 24(S)-hydroxycholesterol: protective effects of \u03b1-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3)","volume":"99","author":"Nury","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.neurot.2026.e01062_bib50","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/jnc.15228","article-title":"24S-hydroxycholesterol: cellular effects and variations in brain diseases","volume":"157","author":"Sodero","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2026.e01062_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80378-y","article-title":"Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis","volume":"11","author":"Dodge","year":"2021","journal-title":"Sci Rep"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:07:05Z","timestamp":1790125625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926002321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1878747926002321"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01062","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological modulation with the LXR agonist T0901317 attenuates motor pathology in the SOD1G93A mouse model of ALS","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01062"}}